1999
DOI: 10.1002/(sici)1097-0142(19990515)85:10<2132::aid-cncr6>3.3.co;2-8
|View full text |Cite
|
Sign up to set email alerts
|

Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
29
0
2

Year Published

2001
2001
2014
2014

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(32 citation statements)
references
References 0 publications
1
29
0
2
Order By: Relevance
“…A subsequent longitudinal study confirmed these results. 68 The incidence of HCC (per 100 person years) was 6.4 in dually-infected patients, compared to 2.0 in HBV and 3.7 in HCV monoinfected patients, while the cumulative risk of developing HCC at 10 years was 45% in coinfected patients, compared with 16% and 28% in HBV and HCV monoinfected disease controls. However, a study from Japan suggested that dual infection was rare (2%) in Japanese patients with liver cirrhosis and did not play an important role in the occurrence of HCC.…”
Section: Impact Of Hbv/hcv Coinfection On Development Of Hccmentioning
confidence: 99%
“…A subsequent longitudinal study confirmed these results. 68 The incidence of HCC (per 100 person years) was 6.4 in dually-infected patients, compared to 2.0 in HBV and 3.7 in HCV monoinfected patients, while the cumulative risk of developing HCC at 10 years was 45% in coinfected patients, compared with 16% and 28% in HBV and HCV monoinfected disease controls. However, a study from Japan suggested that dual infection was rare (2%) in Japanese patients with liver cirrhosis and did not play an important role in the occurrence of HCC.…”
Section: Impact Of Hbv/hcv Coinfection On Development Of Hccmentioning
confidence: 99%
“…Liver cirrhosis is a well-known disease underlying HCC, 1,24 and the reported incidence of HCC development in patients with cirrhosis ranges 2-6.5% per year. [25][26][27][28][29][30] The incidence of HCC development depends on the geographical area or country, sex and age of the patients, and the etiology and severity of the underlying disease. [24][25][26]31 Early identification of asymptomatic HCC at the stage of compensated cirrhosis enables the consideration of specific treatments such as tumor resection, chemoembolization or local ablative therapy for good survival.…”
Section: Screening For Hccmentioning
confidence: 99%
“…The incidence of HCCs in cirrhotic patients has been reported to be as high as 4% per year, and it is important to perform screening of HCCs by ultrasonography (US) and by checking the level of serum alpha-fetoprotein (aFP). 22,23 Recently, several reports have recommended the use of CT or magnetic resonance (MR) screening instead of ultrasonography (US), particularly in terms of costeffectiveness, and CT or MR are commonly preferred over US for surveillance in the United States and some other countries. [24][25][26][27] Also, in patients treated with ablation therapy or chemoembolization for HCCs, regular follow-up CT examinations are essential to evaluate therapeutic effectiveness and recurrence.…”
Section: Discussionmentioning
confidence: 99%